Medical Device and Diagnostic Magazine (MD+DI) names SynCardia as a top 50 company to watch
The Medical Device and Diagnostic Magazine selected SynCardia because the “Total Artificial Heart” is the only device of its kind with regulatory approval in the Unites States, Canada and Europe. The Artificial Heart is meant for people dying from end stage biventricular failure. There is no waiting list for the Artificial Heart like there is for a donor heart.